Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Steven Barnard Engle Insider Profile
4 Followers
Steven Barnard Engle, Director at Aroa Biosurgery Ltd, holds 859.76K shares in Aroa Biosurgery Ltd (Ticker: AU:ARX).
Steven Barnard Engle has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Steven Barnard Engle's holdings
Insider Roles
Director
Roles that Steven Barnard Engle holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Steven Barnard Engle
Steven Barnard Engle's Trading History
List of latest transactions for each holding click on a transaction to see Steven Barnard Engle's performance on stock
You May Also Like
Steven Barnard Engle insider profile FAQ
What is the percentage of profitable transactions made by Steven Barnard Engle?
The percentage of profitable transactions made by Steven Barnard Engle is ―.
What is the average return per transaction made by Steven Barnard Engle?
The average return per transaction made by Steven Barnard Engle is ―.
What stocks does Steven Barnard Engle hold?
Steven Barnard Engle holds: AU:ARX stocks.
What was Steven Barnard Engle’s latest transaction?
Steven Barnard Engle latest transaction was an Uninformative Sell of AU$61.99K.
What was Steven Barnard Engle's most profitable transaction?
Steven Barnard Engle’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Steven Barnard Engle's role in Aroa Biosurgery Ltd?
Steven Barnard Engle's role in Aroa Biosurgery Ltd is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.